ANI Pharmaceuticals(ANIP) - 2025 Q4 - Earnings Call Transcript

ANI Pharmaceuticals (NasdaqGM:ANIP) Q4 2025 Earnings call February 27, 2026 08:00 AM ET Company ParticipantsBrandon Folkes - Managing DirectorChristopher Mutz - SVP and Head of Rare DiseaseCourtney Mogerley - Managing DirectorGlen Santangelo - Managing DirectorLeszek Sulewski - VP of Spec Pharma and Biotech Equity ResearchNikhil Lalwani - President and CEOStephen Carey - SVP and CFOVamil Divan - Managing DirectorConference Call ParticipantsDavid Amsellem - Managing Director and Senior Research AnalystThomas ...